Esperion Therapeutics
ESPR
#6722
Rank
โ‚น78.50 B
Marketcap
โ‚น304.65
Share price
0.00%
Change (1 day)
41.38%
Change (1 year)

Market capitalization of Esperion Therapeutics (ESPR)

Last known market cap: โ‚น78.50 Billion

As of September 2026 Esperion Therapeutics has a market cap of โ‚น78.50 Billion. This makes Esperion Therapeutics the world's 6722th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Esperion Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น78.50 B-8.69%
2025โ‚น85.97 B123.09%
2024โ‚น38.53 B36.15%
2023โ‚น28.30 B-25.48%
2022โ‚น37.98 B67.6%
2021โ‚น22.66 B-54.01%
2020โ‚น49.27 B-57.86%
2019โ‚น116.92 B35.52%
2018โ‚น86.28 B-21.66%
2017โ‚น110.13 B473.95%
2016โ‚น19.18 B-42.39%
2015โ‚น33.30 B-36.12%
2014โ‚น52.14 B300.4%
2013โ‚น13.02 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
โ‚น15.654 T 19,841.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น7.772 T 9,800.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
โ‚น136.95 B 74.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
โ‚น76.51 B-2.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
โ‚น435.88 B 455.22%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น1.117 T 1,323.46%๐Ÿ‡บ๐Ÿ‡ธ USA